Microplastics in Female Reproductive and Pregnancy Organs: A Systematic Review
Life · 30.04.2026 · 16 (5) · 746
DOI: 10.3390/life16050746 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Life, online erschienen am 30.04.2026. Verfasst von Bielka Carvajal und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Women's and Newborn Health Promotion, Faculty of Medicine, University of Chile, Santiago 8380453, Chile. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research and Development Agency (ANID).
Abstract (Originalsprache)
Background
Microplastics (MPs) have rapidly emerged as pervasive environmental contaminants with growing implications for human health. Evidence now shows that MP exposure may begin during pregnancy and extend into infancy. Foetal exposure to MP raises questions about MP presence within reproductive organs, maternal–foetal MP transfer and the potential impact of MP on women’s reproductive health.
Objectives
To synthesise current evidence on the presence and distribution of microplastics in the female reproductive system and pregnancy-related organs.
Methods
A systematic review of literature was conducted using Embase and Medline databases, supplemented by reference screening and manual searches. Studies were eligible if they examined MP in human female reproductive organs or pregnancy-related tissues and were published in English.
Results
Eleven studies met the inclusion criteria. Across studies, MP detection varied substantially due to differences in sampling protocols, analytical techniques, and particle size detection thresholds. Cross-contamination and analytical method variability remained major methodological concerns. MP were consistently identified in follicular fluid, placental tissue, amniotic fluid, cord blood, and meconium.
Conclusions
The presence of MP in both maternal and foetal compartments supports the possibility of in utero maternal-foetal MP transfer. A standardised protocol should be used to assess MP presence and MP’s impact on organs and tissues. The current variability of diagnostic tests, the lack of cofounding variables control and the reduced sample sizes limit the ability to determine how clinically relevant MP exposure is during pregnancy and to women’s reproductive health.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Women's and Newborn Health Promotion, Faculty of Medicine, University of Chile, Santiago 8380453, Chile.
- Microbiology Interdisciplinary Core, Institute of Biomedical Sciences (ICBM), Faculty of Medicine, University of Chile, Santiago 8380453, Chile.
- Medical Technology School, Universidad del Desarrollo-Alemana Clinic, Santiago 7610658, Chile.
- Clinical Laboratory, Carabineros Hospital (HOSCAR), Santiago 7770201, Chile.
- Department of Nutrition, Faculty of Medicine, University of Chile, Santiago 8380453, Chile.
ORCID-Profile: Bielka Carvajal, Cecilia V Tapia, Martin Gotteland
Förderung
- National Research and Development Agency (ANID)
Zitieren
APA
Carvajal, B., Vivero Sun, R., Piderit, F., Zazueta, A., Tapia, C. V., Gotteland, M., & Magne, F. (2026). Microplastics in Female Reproductive and Pregnancy Organs: A Systematic Review. Life, 16(5), 746. https://doi.org/10.3390/life16050746
Vancouver
Carvajal B, Vivero Sun R, Piderit F, Zazueta A, Tapia CV, Gotteland M, et al. Microplastics in Female Reproductive and Pregnancy Organs: A Systematic Review. Life. 2026;16(5):746. doi:10.3390/life16050746
BibTeX
@article{Carvajal2026,
author = {Carvajal, Bielka and Vivero Sun, Rayen and Piderit, Francisca and Zazueta, Alejandra and Tapia, Cecilia V and Gotteland, Martin and Magne, Fabien},
title = {Microplastics in Female Reproductive and Pregnancy Organs: A Systematic Review},
journal = {Life},
year = {2026},
volume = {16},
number = {5},
pages = {746},
doi = {10.3390/life16050746}
}
EUVIMED